Recall: AVpak Acyclovir Tablet, USP, 400mg, 50ct Unit Dose
On 2018-02-13, the FDA announced that Apace Packaging is conducting a recall on Acyclovir Tablet, USP, 400mg, 50ct Unit Dose due to a possible undetermined hazard. The recalled products were sold under the brand name(s) AVpak during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential undetermined hazard, including intralipid 20% iv fat emulsion, 100 ml, oxytocin and more. Additionally, there have been 19 drug and medical device recalls due to other health hazards as well as 78 food recalls.
Company Contact Information:
Name: Apace Packaging
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Acyclovir Tablet, USP, 400mg, 50ct Unit Dose
Brand Name(s): AVpak
Reason for Recall: Product mix-up
Official Recall Date: 2018-02-13
Additional information provided by the FDA.gov:
Fountain Run, KY, Apace Packaging LLC is voluntarily recalling one lot of Acyclovir Tablet, USP, 400mg, 50ct Unit Dose, NDC# 50268-061-15 (Carton), NDC# 50268-061-11 (Blister Card), Lot Number 19900, to the Retail level. These products have been recalled due to a product mix-up. A small number of blister cards containing Acyclovir Tablets, 400mg, UD Blister Cards may potentially also include Torsemide, 20mg, Tablets. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.